Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy.
about
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAARTPopulation pharmacokinetic analysis for nelfinavir and its metabolite M8 in virologically controlled HIV-infected patients on HAART.Clinical pharmacokinetics of antiretroviral drugs in older persons.Population pharmacokinetic analysis of lamivudine, stavudine and zidovudine in controlled HIV-infected patients on HAART.Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters
P2860
Population pharmacokinetic analysis of indinavir in HIV-infected patient treated with a stable antiretroviral therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Population pharmacokinetic ana ...... stable antiretroviral therapy.
@en
Population pharmacokinetic ana ...... stable antiretroviral therapy.
@nl
type
label
Population pharmacokinetic ana ...... stable antiretroviral therapy.
@en
Population pharmacokinetic ana ...... stable antiretroviral therapy.
@nl
prefLabel
Population pharmacokinetic ana ...... stable antiretroviral therapy.
@en
Population pharmacokinetic ana ...... stable antiretroviral therapy.
@nl
P2093
P2860
P1476
Population pharmacokinetic ana ...... stable antiretroviral therapy.
@en
P2093
Anne-Marie Taburet
Cophar 1-ANRS 102 Trial Group
Cécile Goujard
France Mentré
Gabriel Baron
Karl Brendel
Mayeule Legrand
P2860
P304
P356
10.1111/J.1472-8206.2005.00315.X
P577
2005-06-01T00:00:00Z